Cognitive impairment in persons with rheumatoid arthritis

Arthritis Care and Research

Volumn 64, Issue 8, 2012, Pages 1144-1150

  Shin, So Young ^a   Katz, Patricia ^a   Wallhagen, Margaret ^a   Julian, Laura ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOCORTICOID;

ACADEMIC ACHIEVEMENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GENDER; HUMAN; INCOME; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PREDICTOR VARIABLE; PROGNOSIS; PROTEIN BLOOD LEVEL; RACE; RHEUMATOID ARTHRITIS; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; COGNITION DISORDERS; COHORT STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREVALENCE;

EID: 84864423860     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21683     Document Type: Article

References (47)

1. Bennett D, Wilson R, Schneider J, Evans D, Beckett L, Aggarwal N, et al. Natural history of mild cognitive impairment in older persons. Neurology 2002; 59: 198-205.
2. Abeare CA, Cohen JL, Axelrod BN, Leisen JC, Mosley-Williams A, Lumley MA,. Pain, executive functioning, and affect in patients with rheumatoid arthritis. Clin J Pain 2010; 26: 683-9.
3. Gimeno D, Marmot MG, Singh-Manoux A,. Inflammatory markers and cognitive function in middle-aged adults: the Whitehall II study. Psychoneuroendocrinology 2008; 33: 1322-34.
4. Meyer JS, Rauch GM, Rauch RA, Haque A, Crawford K,. Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia. Ann N Y Acad Sci 2000; 903: 411-23.
5. Bartolini M, Candela M, Brugni M, Catena L, Mari F, Pomponio G, et al. Are behaviour and motor performances of rheumatoid arthritis patients influenced by subclinical cognitive impairments? A clinical and neuroimaging study. Clin Exp Rheumatol 2002; 20: 491-7.
6. Appenzeller S, Bertolo MB, Costallat LT,. Cognitive impairment in rheumatoid arthritis. Methods Find Exp Clin Pharmacol 2004; 26: 339-43.
7. Auyeung T, Kwok T, Lee J, Leung P, Leung J, Woo J,. Functional decline in cognitive impairment: the relationship between physical and cognitive function. Neuroepidemiology 2008; 31: 167-73.
8. Dunlop DD, Semanik P, Song J, Manheim LM, Shih V, Chang RW,. Risk factors for functional decline in older adults with arthritis. Arthritis Rheum 2005; 52: 1274-82.
9. Raji MA, Kuo YF, Snih SA, Markides KS, Peek MK, Ottenbacher KJ,. Cognitive status, muscle strength, and subsequent disability in older Mexican Americans. J Am Geriatr Soc 2005; 53: 1462-8.
10. Katz PP, Morris A, Yelin EH,. Prevalence and predictors of disability in valued life activities among individuals with rheumatoid arthritis. Ann Rheum Dis 2006; 65: 763-9.
11. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
12. Kozora E, Ellison M, West S,. Reliability and validity of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus. Arthritis Rheum 2004; 51: 810-8.
13. Kozora E, Arciniegas DB, Zhang L, West S,. Neuropsychological patterns in systemic lupus erythematosus patients with depression. Arthritis Res Ther 2007; 9: R48.
14. Delis D, Kramer J, Kaplan E, Ober B,. California verbal learning test: adult version. San Antonio (TX): Psychological Corporation; 1987.
15. Rey A, Osterrieth P,. Translations of excerpts from Andre Rey's psychological examination of traumatic encephalopathy and P. A. Osterrieth's "The Complex Figure Copy Test." Clin Neuropsychologist 1993; 7: 3-15.
16. Borkowski J, Benton A, Spreen O,. Word fluency and brain damage. Neuropsychologia 1967; 5: 135-40.
17. Smith A,. Symbol digit modalities test: manual. Rev. 1982. Los Angeles: Western Psychological Services; 1982.
18. Delis D,. Delis-Kaplan Executive Function Scale. San Antonio (TX): Psychological Corporation; 2001.
19. Wechsler D,. Wechsler Adult Intelligence Scale-III (WAIS-III). San Antonio (TX): Psychological Corporation; 1997.
20. Woodard JL, Benedict RH, Roberts VJ, Goldstein FC, Kinner KM, Capruso DX, et al. Short-form alternatives to the Judgment of Line Orientation Test. J Clin Exp Neuropsychol 1996; 18: 898-904.
21. Benton AL,. Contributions to neuropsychological assessment: a clinical manual. New York: Oxford University Press; 1994.
22. Kozora E, Thompson L, West S, Kotzin B,. Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1996; 39: 2035-45.
23. Lecrubier Y, Sheehan D, Weiller E, Amorim P, Bonora I, Harnett Sheehan K, et al. The Mini International Neuropsychiatric Interview (MINI): a short diagnostic structured interview. Reliability and validity according to the CIDI. Eur Psychiatry 1997; 12: 224-31.
24. Sheehan D, Lecrubier Y, Harnett Sheehan K, Janavs J, Weiller E, Keskiner A, et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry 1997; 12: 232-41.
25. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The MINI-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 Suppl 20: 22-33.
26. Stucki G, Liang M, Stucki S, Bruhlmann P, Michel B,. A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research: psychometric properties and correlation with parameters of disease activity. Arthritis Rheum 1995; 38: 795-8.
27. Fransen J, Langenegger T, Michel B, Stucki G,. Feasibility and validity of the RADAI, a self-administered rheumatoid arthritis disease activity index. Rheumatology (Oxford) 2000; 39: 321-7.
28. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117: 743-53.
29. Pencina MJ, D'Agostino RB, Larson MG, Massaro JM, Vasan RS,. Predicting the 30-year risk of cardiovascular disease. Circulation 2009; 119: 3078-84.
30. Lynch JW, Kaplan GA, Shema SJ,. Cumulative impact of sustained economic hardship on physical, cognitive, psychological, and social functioning. N Engl J Med 1997; 337: 1889-95.
31. Adler NE, Ostrove JM,. Socioeconomic status and health: what we know and what we don't. Ann N Y Acad Sci 1999; 896: 3-15.
32. Lee S, Kawachi I, Berkman LF, Grodstein F,. Education, other socioeconomic indicators, and cognitive function. Am J Epidemiol 2003; 157: 712-20.
33. Cagney KA, Lauderdale DS,. Education, wealth, and cognitive function in later life. J Gerontol B Psychol Sci Soc Sci 2002; 57: P163-72.
34. Belanoff JK, Gross K, Yager A, Schatzberg AF,. Corticosteroids and cognition. J Psychiatr Res 2001; 35: 127-45.
35. Wolkowitz OM, Reus VI, Weingartner H, Thompson K, Breier A, Doran A, et al. Cognitive effects of corticosteroids. Am J Psychiatry 1990; 147: 1297-303.
36. Knopman D, Boland L, Mosley T, Howard G, Liao D, Szklo M, et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001; 56: 42-8.
37. Singh-Manoux A, Sabia S, Lajnef M, Ferrie JE, Nabi H, Britton AR, et al. History of coronary heart disease and cognitive performance in midlife: the Whitehall II study. Eur Heart J 2008; 29: 2100-7.
38. Chui H,. Dementia due to subcortical ischemic vascular disease. Clin Cornerstone 2001; 3: 40-51.
39. Maradit Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005; 52: 402-11.
40. Roifman I, Beck PL, Anderson TJ, Eisenberg MJ, Genest J,. Chronic inflammatory diseases and cardiovascular risk: a systematic review. Can J Cardiol 2011; 27: 174-82.
41. Mazzantini M, Talarico R, Doveri M, Consensi A, Cazzato M, Bazzichi L, et al. Incident comorbidity among patients with rheumatoid arthritis treated or not with low-dose glucocorticoids: a retrospective study. J Rheumatol 2010; 37: 2232-6.
42. Panoulas VF, Douglas KM, Stavropoulos-Kalinoglou A, Metsios GS, Nightingale P, Kita M, et al. Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis. Rheumatology (Oxford) 2008; 47: 72-5.
43. Davis JM III, Maradit Kremers H, Crowson CS, Nicola PJ, Ballman KV, Therneau TM, et al. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2007; 56: 820-30.
44. Yaffe K, Lindquist K, Penninx B, Simonsick E, Pahor M, Kritchevsky S, et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 2003; 61: 76-80.
45. Shucard JL, Gaines JJ, Ambrus J Jr, Shucard DW,. C-reactive protein and cognitive deficits in systemic lupus erythematosus. Cogn Behav Neurol 2007; 20: 31-7.
46. Hart RP, Wade JB, Martelli MF,. Cognitive impairment in patients with chronic pain: the significance of stress. Curr Pain Headache Rep 2003; 7: 116-26.
47. Chodosh J, Kado DM, Seeman TE, Karlamangla AS,. Depressive symptoms as a predictor of cognitive decline: MacArthur studies of successful aging. Am J Geriatr Psychiatry 2007; 15: 406-15.